The head of the Syndicate of Iranian Holders of Human Pharmaceutical Industries, Abbas Kebriyayizade, said that three medicines with Iranian formulas will be jointly produced in Russia.
His comments came after major Iranian and Russian pharmaceutical manufacturers signed an agreement in March to localize production of an influenza vaccine in Iran.
According to the deal, Iran’s Sobhan Recombinant Protein firm and Russia’s Petrovax company will jointly produce the Russian-developed 'Grippol Plus' flu vaccine in Iran, Tasnim reports.
